ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 171 filers reported holding ANI PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $428,000 | +27.8% | 5,875 | +44.0% | 0.16% | +5.9% |
Q2 2019 | $335,000 | -46.5% | 4,079 | -54.0% | 0.15% | -50.6% |
Q1 2019 | $626,000 | +130.1% | 8,876 | +118.0% | 0.31% | +47.4% |
Q2 2018 | $272,000 | -37.8% | 4,072 | -51.1% | 0.21% | -40.8% |
Q3 2017 | $437,000 | – | 8,334 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |